Findings from 1918 Flu Pandemic research could help improve current health policies

The 1918 Flu Pandemic infected over 500 million people, killing at least 50 million. Now, a researcher at the University of Missouri has analyzed the pandemic in two remote regions of North America, finding that despite their geographical divide, both regions had environmental, nutritional and economic factors that influenced morbidity during the pandemic. Findings from the research could help improve current health policies.

"Epidemics such as the Black Death in the 14th century, cholera in the 19th century and malaria have been documented and recorded throughout history," said Lisa Sattenspiel, professor of anthropology in the College of Arts and Science at MU. "While it is probably impossible to consider all the dimensions of pandemics, such as cultural, social and political factors, we can get a 'snapshot' by pinpointing similar areas. Our research focused on the 1918 influenza pandemic in Labrador, Canada and Alaska, which are widely separated in space, yet have similar geographic and environmental constraints as well as ethnic overlap."

By analyzing death records and community history, Sattenspiel and her fellow researcher, Svenn-Erik Mamelund, senior researcher at the Work Research Institute of Oslo, found that both Labrador and Alaska were devastated by the 1918 pandemic. Beginning in January 1918 and lasting through December 1920, both regions experienced higher mortality rates than most other parts of the world-34 percent and 8 percent, respectively.

Archival materials from Labrador and Alaska indicated that circulating pathogens, including pneumonia and tuberculosis, played a role in morbidity. Environmental influences, including harsh, stressful winters, and nutritional factors, such as lack of food, also played a role in susceptibility to influenza. Sattenspiel says that during the summer months in Labrador the influx of infected commercial fishermen played an important role in the milder first wave of the pandemic, while during the severe second (fall and winter) wave, the movements of fur traders and hunters were more important. Additionally, researchers found that transmission rates were higher in harsher climates where a greater proportion of daily life is conducted indoors.

"Inadequate access to health care contributed to higher mortality rates in the regions studied," Sattenspiel said. "Our findings indicate that today's infectious disease planning should include evaluating the placement of nurses and trained health care professionals who can administer vaccines and treatment. Programs that improve housing conditions and crowding may also help reduce disease transmission. Finally, contingency plans must take into account the remoteness of an area as well as distance to population centers and health care facilities."

Sattenspiel says that lessons learned from 20th century Labrador and Alaska illustrate how important it is to take a systemic approach if health officials are to improve our response to future infectious disease pandemics in today's world.

Her study, "Cocirculating epidemics, chronic health problems, and social conditions in early 20th century Labrador and Alaska," was published in the Annals of Anthropological Practice.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy